{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:23:57Z","timestamp":1775255037800,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T00:00:00Z","timestamp":1449187200000},"content-version":"vor","delay-in-days":337,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.atherosclerosis.2014.11.020","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T15:41:49Z","timestamp":1416670909000},"page":"132-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner"],"prefix":"10.1016","volume":"238","author":[{"given":"Anouk","family":"Wezel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna M.","family":"Maassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Maxime","family":"Lagraauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet R.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacco C.","family":"Karper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics \u2013 2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (*)","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/CS20120576","article-title":"Immunological aspects of atherosclerosis","volume":"125","author":"Woollard","year":"2013","journal-title":"Clin. Sci. Lond."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000348795","article-title":"The complexity of arterial classical monocyte recruitment","volume":"5","author":"Drechsler","year":"2013","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH11-05-0291","article-title":"Mast cells in atherosclerosis","volume":"106","author":"Bot","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib9","doi-asserted-by":"crossref","first-page":"393946","DOI":"10.1155\/2010\/393946","article-title":"The expression and functions of toll-like receptors in atherosclerosis","volume":"2010","author":"Cole","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls","volume":"108","author":"Mann","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/ATVBAHA.112.249847","article-title":"Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice","volume":"32","author":"Ding","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/JOE-12-0338","article-title":"TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"216","author":"Lu","year":"2013","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.0107021","article-title":"Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105","volume":"82","author":"Divanovic","year":"2007","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.coi.2008.07.001","article-title":"TLR accessory molecules","volume":"20","author":"Akashi-Takamura","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni1198","article-title":"Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105","volume":"6","author":"Divanovic","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nsmb.2106","article-title":"An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1","volume":"18","author":"Yoon","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jmb.2011.09.020","article-title":"Crystal structures of mouse and human RP105\/MD-1 complexes reveal unique dimer organization of the toll-like receptor family","volume":"413","author":"Ohto","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib18","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/ATVBAHA.113.301882","article-title":"An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation","volume":"33","author":"Karper","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib19","doi-asserted-by":"crossref","first-page":"e67923","DOI":"10.1371\/journal.pone.0067923","article-title":"TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation","volume":"8","author":"Karper","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.103.8.1164","article-title":"Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice","volume":"103","author":"von der Th\u00fcsen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib21","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.4049\/jimmunol.154.7.3333","article-title":"RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family","volume":"154","author":"Miyake","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1369\/0022155411416007","article-title":"Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties","volume":"59","author":"Francke","year":"2011","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.192.1.23","article-title":"The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells","volume":"192","author":"Ogata","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jvs.2009.03.027","article-title":"Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice","volume":"50","author":"Eefting","year":"2009","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2004-12-4839","article-title":"Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown ofCCR2 function in\u00a0vivo","volume":"106","author":"Bot","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCRESAHA.111.263186","article-title":"Lymphocytes and the adventitial immune response in atherosclerosis","volume":"110","author":"Campbell","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B\u00a0cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.0000260802.75766.00","article-title":"Monocyte\/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques","volume":"100","author":"Stoneman","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib29","doi-asserted-by":"crossref","first-page":"e99882","DOI":"10.1371\/journal.pone.0099882","article-title":"TLR4 accessory molecule RP105 (CD180) regulates monocyte-driven arteriogenesis in a murine hind limb ischemia model","volume":"9","author":"Bastiaansen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1189\/jlb.0307191","article-title":"Monocyte subpopulations and their differentiation patterns during infection","volume":"82","author":"Strauss-Ayali","year":"2007","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00318-9","article-title":"Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"143","author":"Dawson","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib33","doi-asserted-by":"crossref","first-page":"e30404","DOI":"10.1371\/journal.pone.0030404","article-title":"TLR signaling paralyzes monocyte chemotaxis through synergized effects of p38 MAPK and global Rap-1 activation","volume":"7","author":"Yi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X","article-title":"Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression","volume":"30","author":"Xu","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CVI.13.1.156-159.2006","article-title":"Human endotoxemia induces down-regulation of monocyte CC chemokine receptor 2","volume":"13","author":"Heesen","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib36","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.172.8.4977","article-title":"Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells","volume":"172","author":"Parker","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1179\/096805105X67300","article-title":"Inhibition of TLR4\/MD-2 signaling by RP105\/MD-1","volume":"11","author":"Divanovic","year":"2005","journal-title":"J.\u00a0Endotoxin Res."},{"key":"10.1016\/j.atherosclerosis.2014.11.020_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014015834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014015834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:02:58Z","timestamp":1689685378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014015834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0021915014015834"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.11.020","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}